These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20647637)

  • 1. Application of drug eluting stents to clinical practice in Japan: are we going in the right direction?
    Aoki J
    Circ J; 2010 Aug; 74(8):1532-3. PubMed ID: 20647637
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug-eluting coronary stents].
    Zeus T; Kelm M; Nitschmann S
    Internist (Berl); 2014 Jan; 55(1):103-6. PubMed ID: 24399477
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of restenosis in drug-eluting stents: still a challenge!
    Gupta M; Kadakia J; Budoff MJ
    J Invasive Cardiol; 2010 May; 22(5):220-1. PubMed ID: 20440038
    [No Abstract]   [Full Text] [Related]  

  • 4. Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
    Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2007 Nov; 50(21):2037-8. PubMed ID: 18021869
    [No Abstract]   [Full Text] [Related]  

  • 5. The drug-eluting stent saga.
    Windecker S; Jüni P
    Circulation; 2009 Feb; 119(5):653-6. PubMed ID: 19204314
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents in animals and patients: where do we stand today?
    Drachman DE
    Circulation; 2009 Jul; 120(2):101-3. PubMed ID: 19564555
    [No Abstract]   [Full Text] [Related]  

  • 8. Left main coronary artery stenting: crossing the Rubicon.
    Alfonso F
    J Am Coll Cardiol; 2009 May; 53(19):1769-72. PubMed ID: 19422983
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-eluting stent for long coronary artery disease.
    Park SJ; Kim YH
    Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-eluting stents: safe but not sufficient.
    Vogel RA
    JACC Cardiovasc Interv; 2009 Jun; 2(6):513-4. PubMed ID: 19539254
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug eluting stents for saphenous vein graft interventions.
    Banerjee S; Master R; Iqbal A; Brilakis ES
    Minerva Cardioangiol; 2011 Jun; 59(3):235-8. PubMed ID: 21516072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentation and outcomes.
    Vidi VD; Arora N
    J Invasive Cardiol; 2010 Jun; 22(6):271-2. PubMed ID: 20516506
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
    Okmen AS; Okmen E
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):325-30. PubMed ID: 19666436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stents for the treatment of coronary artery disease: NICE technology appraisal guidance.
    Messori A; Trippoli S
    Heart; 2009 May; 95(10):847. PubMed ID: 19401286
    [No Abstract]   [Full Text] [Related]  

  • 16. Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial.
    Silber S; Windecker S; Vranckx P; Serruys PW;
    Lancet; 2011 Apr; 377(9773):1241-7. PubMed ID: 21459430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
    Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
    Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents.
    Klomp M; Beijk MA; Varma C; Koolen JJ; Teiger E; Richardt G; Bea F; van Geloven N; Verouden NJ; Chan YK; Woudstra P; Damman P; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2011 Aug; 4(8):896-904. PubMed ID: 21851905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of drug-eluting stent length on outcomes less is more...more or less.
    Fearon WF
    JACC Cardiovasc Interv; 2010 Feb; 3(2):189-90. PubMed ID: 20170876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.